Page 83 - Abt News Today

Health-care companies declined as traders stepped back from makers of Covid 19 products. Pfizer tumbled to the lowest level since mid2020 as investors braced...

Worries that new weight loss drugs will impact demand for continuous glucose monitoring devices have gone too far.

By Dean Seal Abbott Labs is slated to report third-quarter results on Wednesday morning. Here's what you need to know. PROFIT: The Abbott Park, Ill.-based...

Klingman & Associates LLC lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.9% in the second quarter, according to its most recent filing with the SEC. The firm owned 7,937 shares of the healthcare product maker’s stock after selling 239 shares during the period. Klingman & Associates LLC’s holdings in […]

Victory Capital Management Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 616,690 shares of the healthcare product maker’s stock after selling 15,227 shares during the period. Victory Capital Management Inc.’s holdings […]

Arcblock (ABT) traded down 2.7% against the U.S. dollar during the one day period ending at 17:00 PM E.T. on October 15th. Over the last seven days, Arcblock has traded 11.6% lower against the U.S. dollar. Arcblock has a market capitalization of $6.67 million and $129,655.37 worth of Arcblock was traded on exchanges in the […]

KBC Group NV trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 2.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,697,965 shares of the healthcare product maker’s stock after selling 50,031 shares during the period. Abbott Laboratories comprises approximately […]

Novare Capital Management LLC raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 95,661 shares of the healthcare product maker’s stock after purchasing an additional 879 shares during the period. Abbott Laboratories comprises approximately 1.1% of […]

Private Capital Advisors Inc. lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 26.0% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,674 shares of the healthcare product maker’s stock after selling 5,500 shares during the quarter. Private […]

Northstar Asset Management LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,771 shares of the healthcare product maker’s stock after purchasing an additional 125 shares during the quarter. Northstar […]